Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 234 of 5804
-
New hope for HIV patients: shorter, stronger fungal infection treatment on trial
Disease control Not yet recruitingLAmB-FAST is a factorial randomized controlled trial simultaneously testing two interventions in one trial. LAmB-FAST seeks to inform treatment guidelines on the induction and maintenance therapy of HIV-associated talaromycosis (formerly called penicilliosis) and will answer the …
Phase: PHASE3 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cancer trial aims to crack the code of who benefits from immunotherapy
Knowledge-focused Not yet recruitingOver the past decade, cancer immunotherapy has profoundly transformed oncology by harnessing the patient's immune system to target tumors. These therapies have demonstrated the potential for durable responses and, in some cases, long-term remission or cure. However, despite these…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Massive heart failure platform trial aims to find better treatments
Disease control Not yet recruitingThe Heart Failure Efficacy and Research Trial (HEART) Platform is a multicenter, randomized platform study designed to improve outcomes for patients with heart failure through the simultaneous and sequential evaluation of multiple interventions across the spectrum of heart failur…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Veterans helping veterans: One-Hour chat could save lives from firearm suicide
Prevention Not yet recruitingSuicide prevention is a top priority for the Department of Veterans Affairs (VA), with a major emphasis on developing innovative and effective ways to prevent firearm suicide. Research suggests that secure firearm storage can decrease risk for suicide and the current project aims…
Phase: PHASE1, PHASE2 • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
New study to track gene Therapy's Real-World impact on spinal muscular atrophy
Disease control Not yet recruitingThe primary purpose is to address critical evidence in the treatment landscape for Spinal Muscular Atrophy (SMA), specifically focusing on the intrathecal formulation of onasemnogene abeparvovec-brve (ITVISMA®). U.S. Pragmatic Multicenter Study (STREAM).
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Pre-Surgery combo aims to boost cancer fight in stomach and esophageal tumors
Disease control Not yet recruitingThis trial is designed to evaluate a total neoadjuvant approach using D-FLOT as the new standard backbone in patients with resectable esophagogastric adenocarcinoma. It addresses major limitations of current treatment paradigms, builds directly on the strong clinical signal from …
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could 8 weeks of steroids be enough? new trial aims to cut treatment time for GCA
Disease control Not yet recruitingThe GISCO study plans to determine whether 8-week therapy is just as effective as 26-week cortisone therapy for treating giant cell arteritis * with tocilizumab, * while using less cortisone.
Phase: PHASE3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can remote monitoring and community support tame postpartum high blood pressure?
Disease control Not yet recruitingThe goal of this randomized clinical trial is to evaluate the effectiveness of a collaborative care intervention, consisting of remote blood pressure monitoring and support from community health workers, in improving blood pressure control and reducing postpartum complications am…
Phase: NA • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New balloon ablation could change early AFib treatment
Disease control Not yet recruitingThis study is a prospective, multicenter, randomized, open-label, blinded end-point, controlled clinical trial to investigate the impact of first line pulsed field ablation during 12 months follow-up in patients with early-stage paroxysmal or persistent atrial fibrillation (\<3 y…
Phase: NA • Sponsor: Asklepios proresearch • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Anti-Inflammatory drug may boost cancer therapy in bile duct cancer
Disease control Recruiting nowThis study aims to evaluate whether adding celecoxib to standard therapy can improve clinical outcomes in patients with advanced intrahepatic cholangiocarcinoma. The current standard treatment typically consists of immunotherapy combined with chemotherapy; however, there are sign…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Exercise program aims to boost strength in young cancer patients
Symptom relief Not yet recruitingThe BEPPO study is a Germany-wide clinical trial investigating whether a structured exercise program can improve physical and mental health in children and adolescents undergoing cancer treatment. Although exercise is known to support recovery and well-being, it is not yet a stan…
Phase: NA • Sponsor: Universität Duisburg-Essen • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Liver biopsy during machine perfusion may reveal organ viability before transplant
Knowledge-focused Not yet recruitingLiver transplantation is a life-saving treatment for patients with severe liver disease. Because of the shortage of donor organs, transplant centers increasingly use donor livers that may be more vulnerable to injury and dysfunction. To improve the quality of these organs before …
Phase: NA • Sponsor: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Engineered donor cells aim to shield transplant patients from dangerous viruses
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether giving patients a special type of donor immune cells (called CD45RA Depleted DLI) can help prevent viral infections after a stem cell transplant. It will also learn about the safety of this treatment. The main questions it aims …
Phase: PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Off-the-Shelf immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis is a single-arm, open-label, dose-escalation, prospective exploratory clinical study intended to evaluate the safety, efficacy and cellular pharmacokinetics of GT737 cells in adult patients with relapsed/refractory acute myeloid leukemia (AML).
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Smart breathing machines at home could cut hospital visits for COPD patients
Disease control Not yet recruitingThe purpose of this study is to evaluate the effectiveness and clinical efficiency of combining home non-invasive ventilation (NIV) with a continuous remote telemonitoring (TM) system in patients with Chronic Obstructive Pulmonary Disease (COPD) and persistent hypercapnia. In sta…
Sponsor: Air Liquide Healthcare Spain • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New PET scan could predict who benefits from targeted lung cancer therapy
Disease control Not yet recruitingThe primary objective is to evaluate the correlation between ⁶⁸Ga-MY6349 PET/CT-derived metrics reflecting tumoral TROP2 expression activity (including SUVmax, SUVmean, MTV, TLG, etc.) and progression-free survival (PFS) assessed per RECIST v1.1. This study plans to enroll 100 EG…
Phase: PHASE2 • Sponsor: Zhou Chengzhi • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a daily pill slow Alzheimer's? new trial tests SAR448851
Disease control Not yet recruitingThis is a randomized, placebo-controlled Phase 2 study to evaluate the efficacy and safety of SAR448851 in early Alzheimer's disease (AD) participants. The purpose of this study is to measure efficacy and safety with once daily oral SAR448851 compared to placebo in participants w…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug cocktail targets tough esophageal cancer
Disease control Not yet recruitingThis study is a prospective, single-arm, single-center Phase Ib clinical trial of Becotatug Vedotin in combination with cisplatin and concurrent radiotherapy for locally advanced esophageal squamous cell carcinoma. The primary objectives are to investigate the maximum tolerated d…
Phase: PHASE1 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can removing bladder tumors in one piece improve cancer outcomes?
Disease control Not yet recruitingThis is a prospective, multi-centre randomised trial comparing between cTURBT plus 1-year BCG therapy, and ERBT plus 1-year BCG therapy, in patients with intermediate-risk or high-risk NMIBC.
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
Disease control Not yet recruitingThis multicenter, three-arm randomized controlled trial will evaluate the effects of early time-restricted eating and staple food reduction, each combined with an app-supported exercise intervention, on body weight and glycemic control among adults with obesity and abnormal gluco…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC